pLenti-Crispr-V2-HMID.v1 Citations (4)

Originally described in: Whole organism lineage tracing by combinatorial and cumulative genome editing.
McKenna A, Findlay GM, Gagnon JA, Horwitz MS, Schier AF, Shendure J Science. 2016 May 26. pii: aaf7907. PubMed Journal

---

Articles Citing pLenti-Crispr-V2-HMID.v1

Articles
NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. Ramakrishnan G, Parajuli P, Singh P, Friend C, Hurwitz E, Prunier C, Razzaque MS, Xu K, Atfi A. Cell Rep. 2022 Nov 8;41(6):111623. doi: 10.1016/j.celrep.2022.111623. PubMed
USP32-regulated LAMTOR1 ubiquitination impacts mTORC1 activation and autophagy induction. Hertel A, Alves LM, Dutz H, Tascher G, Bonn F, Kaulich M, Dikic I, Eimer S, Steinberg F, Bremm A. Cell Rep. 2022 Dec 6;41(10):111653. doi: 10.1016/j.celrep.2022.111653. PubMed
Identification of XAF1 as an endogenous AKT inhibitor. Chen M, Wang K, Han Y, Yan S, Yuan H, Liu Q, Li L, Li N, Zhu H, Lu D, Wang K, Liu F, Luo D, Zhang Y, Jiang J, Li D, Zhang L, Ji H, Zhou H, Chen Y, Qin J, Gao D. Cell Rep. 2023 Jul 25;42(7):112690. doi: 10.1016/j.celrep.2023.112690. Epub 2023 Jun 27. PubMed
Proteomics of immune cells from liver tumors reveals immunotherapy targets. Canale FP, Neumann J, von Renesse J, Loggi E, Pecoraro M, Vogel I, Zoppi G, Antonini G, Wolf T, Jin W, Zheng X, La Barba G, Birgin E, Forkel M, Nilsson T, Marone R, Mueller H, Pelletier N, Jeker LT, Civenni G, Schlapbach C, Catapano CV, Seifert L, Seifert AM, Gillessen S, De Dosso S, Cristaudi A, Rahbari NN, Ercolani G, Geiger R. Cell Genom. 2023 May 30;3(6):100331. doi: 10.1016/j.xgen.2023.100331. eCollection 2023 Jun 14. PubMed

If you have published an article using this material, please email us at to have your article added to this page.